跳至主要内容
临床试验/NL-OMON36714
NL-OMON36714招募中不适用

The effects of 4 weeks oral administration of omega-3 fatty acids on hepatic steatosis and insulin sensitivity in morbidly obese patients undergoing gastric bypass surgery. - FAT trial (Fatty Acids Treatment trial)

Academisch Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • MRS suggesting NAFLD
  • 18-65 years of age
  • Morbid obesity
  • Ability to provide informed consent.
  • Stable weight 2 months prior to inclusion

排除标准

  • Use of lipid lowering drugs (i.e., statins and fibrate drugs)
  • Any medical condition execpt for hypertension, dyslipidemia, glucose intolerance, treated hypothyroidism, coagulation disorders (increased bleeding time PT, aPTT)
  • Excessive alcohol intake - > > 14 units/week
  • Contraindications to MR scanning - pacemaker or metallic foreign body, claustrophobia etc.
  • Use of n-3 PUFA supplements within the prior 4 months,
  • Pregnancy, females who are breastfeeding.

研究者

相似试验